Evolution of Asthma Therapy to Improve Outcomes
Highlights from the Hopkins' Symposia Series
Activity Date: September 2002  — Activity Info: Volume 2, (14)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity


The contents of this issue of Advanced Studies in Medicine include 2 review articles based on the course curriculum for the Hopkins Symposia series titled "Evolution of Asthma Therapy to Improve Outcomes," and a case study.


    Peter S. Creticos, MD
    Associate Professor of Medicine
    Clinical Director, Division of Allergy and Clinical Immunology
    Johns Hopkins University School of Medicine
    Medical Director, Asthma and Allergy Diseases
    Johns Hopkins Asthma and Allergy Center
    Baltimore, Maryland
    • Dr Creticos reports receiving grants and/or research support from, serving as a consultant to, or being a member of the speakers' bureau for Aradigm, Aventis, AstraZeneca Pharmaceuticals LP, Dynavax Technologies, GlaxoSmithKline, Merck & Co, Inc, Pfizer, Pilot Therapeutics, Schering-Plough, and Stallergenes.


    David Stempel, MD
    Associate Clinical Professor of Pediatrics
    Virginia Mason Clinic
    University of Washington School of Medicine
    Seattle, Washington
    • Dr Stempel reports serving on the speakers' bureau for and as a consultant to GlaxoSmithKline.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

Home | Contact Us | View Account | Need Help?